Bpmx

BioPharmX Corporation (BPMX) (Delayed Data from AMEX) $1.20 USD -0.01 (-0.83%)

The company currently has two advanced drug candidates in the pipeline. The most advanced candidate is designated BPX-01, which has completed Phase 2 and is on its way to Phase 3. It’s a drug that treats inflammatory lesions of acne. Jan 04, 2021 · Company Name: BioPharmX Corp., Stock Symbol: BPMX, Industry: Medical - Drugs, Total Posts: 3061, Last Post: 1/4/2021 12:08:53 PM BPMX. BPMX.

01.02.2021 Bpmx

BMX Photography, photos. Mostly of our local tracks. Feb 14, 2021 · Biopharmx Corp (NYSEAMERICAN:BPMX) shares traded up 3.1% during trading on Friday . The company traded as high as $2.35 and last traded at $2.35. 9,278,542 shares changed hands during mid-day trading, an increase of 331% from the average session volume of 2,150,348 shares. BPMX stock quote, chart and news. Get Timber Pharmaceuticals, Inc.'s stock price today.

18 May 2020 Barchart Technical Opinion · BPMX Related ETFs · Business Summary · BPMX Related stocks · Key Turning Points.

2021. 1. 10.

All items used in analyzing the odds of distress are taken from the BioPharmX balance sheet as well as cash flow and income statements available from the

With a price/sales ratio of 1,474.06, BioPharmX Corp has a higher such ratio than 99.74% of stocks in our set. As for revenue growth, note that BPMX's revenue has grown -92.96% over the past 12 months; that beats the revenue growth of merely 0.74% of US companies in our set. BPMX, $BPMX, stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators Market Data is delayed by 15 minutes and is for informational and/or educational purposes only. In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination. About BPMX BioPharmX Corp.

For example, a 1000 share position pre-split, became a 40 share position following the split. BPMX, $BPMX, stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators 2020. 2.

2. 18. · EX-10.1 2 bpmx-20200218ex1015ca3a4.htm EX-10.1 Sublease Agreement Sublessor: BioPharmX, Inc. Subleased Premises: 115 Nicholson Lane San Jose CA 95134. Sublessee: Full Cycle Bioplastics Inc. Date: 1/15/2020 .

Company Name: BioPharmX Corp., Stock Symbol: BPMX, Industry: Medical - Drugs, Total Posts: 3061, Last Post: 1/4/2021 12:08:53 PM 2021. 2. 24. · Top Penny Stocks. Top penny stocks today to find best penny stocks to buy for February 2021. This list of penny stocks under $1 allowing traders to find hot penny stocks to watch. The best penny stocks today shows the biggest penny stock gainers and losers sorted by percentage.

2021. 2. 14. · Biopharmx Corp (NYSEAMERICAN:BPMX) shares traded up 3.1% during trading on Friday . The company traded as high as $2.35 and last traded at $2.35.

Interactive Chart. 1W 1M 3M 6M YTD 1Y 5Y 10Y MAX. Price Vs S&P500. BPMX S&P 500 Index News & Analysis: BioPharmX Corp. BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter ended A naive forecasting model for BioPharmX is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of BioPharmX value for a given trading day is simply the observed value for the previous period. Michael Tyler predicted that BPMX for Jan. 28th is going $0.87 (13.36%) 1 year ago PumpTheseNumbers predicted that BPMX for 2019-12-12 is going $0.35 (-54.55%) BigCharts was unable to find a security, fund or index matching "bpmx". Company Exchange Symbol Go to: (Version 1.0.0.3) For best experience, it is recommended to use updated Google Chrome browser.

1 milion španělských pesos v librách
program výhod amazon
jak nakupovat kryptoměnu yuan
víza sponzorování pracovních míst kanada
gdax krypto

BioPharmX Corporation (BPMX) (Delayed Data from AMEX) $1.20 USD -0.01 (-0.83%)

Biopharmx Corp (NYSEAMERICAN:BPMX) announced its earnings results on Tuesday, December, 10th. The biotechnology company reported ($1.68) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($2.64) by $0.96.